Researchers are working on multiple innovative approaches to cancer vaccines, including nanoparticle delivery, a universal booster, and more.
The new year began with the good news that death rates from cancer are continuing their steady decline. A...
Around 400 BC, the Greek physician Hippocrates is believed to have first described tumors as “cancer,” using the words...
In the final days of 2019, the U.S. Food and Drug Administration (FDA) expanded the use of a previously...
In 2019, research continued to drive progress across the spectrum of cancer care in the form of new and...
In November and the first half of December, the U.S. Food and Drug Administration (FDA) announced three approvals for...
As the year winds down, here’s our final edition of Editors’ Picks for 2019. This regular feature highlights one...
Immunotherapeutic advances have dramatically changed the treatment landscape for a host of different cancer types. Notably, immune checkpoint inhibitors...
Editor’s note: When the San Antonio Breast Cancer Symposium (SABCS) kicks off next week, researchers will present the results...
As 2019 draws to a close, the American Association for Cancer Research (AACR) is grateful for our growing ranks...
Each month, the editors from the portfolio of scientific journals published by the American Association for Cancer Research (AACR)...